{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:53:59Z","timestamp":1792180439186,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1053\/j.semdp.2023.12.002","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T21:11:01Z","timestamp":1702588261000},"page":"28-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hereditary papillary renal cell carcinoma"],"prefix":"10.1053","volume":"41","author":[{"given":"Isa Mulingbayan","family":"Jacoba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8402-3830","authenticated-orcid":false,"given":"Zhichun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.semdp.2023.12.002_bib0001","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"J Urol"},{"issue":"3 Pt 2","key":"10.1053\/j.semdp.2023.12.002_bib0002","first-page":"907","article-title":"Hereditary papillary renal cell carcinoma: clinical studies in 10 families","volume":"153","author":"Zbar","year":"1995","journal-title":"J Urol"},{"issue":"5","key":"10.1053\/j.semdp.2023.12.002_bib0003","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOU.0000000000000094","article-title":"Nephron-sparing surgery for multifocal and hereditary renal tumors","volume":"24","author":"Metwalli","year":"2014","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1053\/j.semdp.2023.12.002_bib0004","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.semdp.2023.12.002_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-4608(95)00044-5","article-title":"Cytogenetic characterization of a familial papillary renal cell carcinoma","volume":"84","author":"Bernu\u00e9s","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"10.1053\/j.semdp.2023.12.002_bib0006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000134448","article-title":"Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization","volume":"75","author":"Bentz","year":"1996","journal-title":"Cytogenet Cell Genet"},{"issue":"12","key":"10.1053\/j.semdp.2023.12.002_bib0007","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Vande Woude GF. Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1053\/j.semdp.2023.12.002_bib0008","first-page":"230","article-title":"Role of HGF\/SF and c-Met in morphogenesis and metastasis of epithelial cells","volume":"212","author":"Birchmeier","year":"1997","journal-title":"Ciba Found Symp"},{"issue":"11","key":"10.1053\/j.semdp.2023.12.002_bib0009","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3390\/genes13112122","article-title":"Tumorigenesis mechanisms found in hereditary renal cell carcinoma: a review","volume":"13","author":"Webster","year":"2022","journal-title":"Genes (Basel)"},{"issue":"5","key":"10.1053\/j.semdp.2023.12.002_bib0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1200\/JCO.2013.50.8192","article-title":"Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management","volume":"32","author":"Shuch","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2023.12.002_bib0011","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.12.002_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-5347(05)67893-7","article-title":"Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer","volume":"163","author":"Ornstein","year":"2000","journal-title":"J Urol"},{"issue":"4 Pt 1","key":"10.1053\/j.semdp.2023.12.002_bib0013","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","article-title":"Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene","volume":"172","author":"Schmidt","year":"2004","journal-title":"J Urol"},{"issue":"7","key":"10.1053\/j.semdp.2023.12.002_bib0014","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/PAS.0000000000000870","article-title":"Biphasic squamoid alveolar renal cell carcinoma: 2 cases in a family supporting a continuous spectrum with papillary Type I renal cell carcinoma","volume":"41","author":"Chartier","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.12.002_bib0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41379-020-0645-6","article-title":"MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features","volume":"34","author":"Denize","year":"2021","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2023.12.002_bib0016","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/humu.24313","article-title":"Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I","volume":"43","author":"Sebai","year":"2022","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1053\/j.semdp.2023.12.002_bib0017","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13000-021-01170-8","article-title":"Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report","volume":"16","author":"Ferlicot","year":"2021","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.12.002_bib0018","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1158\/0008-5472.CAN-05-0617","article-title":"Inactivation of von Hippel-Lindau gene induces constitutive phosphorylation of MET protein in clear cell renal carcinoma","volume":"66","author":"Nakaigawa","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1053\/j.semdp.2023.12.002_bib0019","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3892\/ijo.2012.1728","article-title":"HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K\/Akt, MAPK and STAT3, in CT26 murine cells","volume":"42","author":"Matsumura","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1053\/j.semdp.2023.12.002_bib0020","series-title":"PDQ Cancer Information Summaries [Internet]","article-title":"Hereditary papillary renal carcinoma (PDQ\u00ae): health professional version. 2022 Dec 28","year":"2002"},{"issue":"1","key":"10.1053\/j.semdp.2023.12.002_bib0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1053\/j.semdp.2023.12.002_bib0022","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J Urol"},{"issue":"3","key":"10.1053\/j.semdp.2023.12.002_bib0023","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","article-title":"Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience","volume":"165","author":"Herring","year":"2001","journal-title":"J Urol"},{"issue":"2","key":"10.1053\/j.semdp.2023.12.002_bib0024","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2012.43.3383","article-title":"Phase II and biomarker study of the dual MET\/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma","volume":"31","author":"Choueiri","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1053\/j.semdp.2023.12.002_bib0025","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jamaoncol.2020.2218","article-title":"Efficacy of savolitinib vs sunitinib in patients with MET-driven papillary renal cell carcinoma: the SAVOIR phase 3 randomized clinical trial","volume":"6","author":"Choueiri","year":"2020","journal-title":"JAMA Oncol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:24:11Z","timestamp":1760037851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257023001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0740257023001132"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2023.12.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary papillary renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}